Cytek Biosciences, Inc. - Common Stock — États financiers (NASDAQ:CTKB) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Stephens réduit l’objectif de cours de Cytek Biosciences en raison de coûts élevés

Alerte résultats : Cytek Biosciences affiche une croissance du chiffre d’affaires au T1 2026 malgré un BPA manqué

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates

Cytek Biosciences à la conférence TD Cowen : Perspectives stratégiques/n

Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:CTKB) 2026-01-15

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat (NASDAQ:BYND), Avadel Pharmaceuticals (NASDAQ:AVDL)